Related references
Note: Only part of the references are listed.IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer
Mads Gyrd-Hansen et al.
NATURE REVIEWS CANCER (2010)
Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo
Hiroyuki Shibata et al.
CANCER SCIENCE (2009)
Curcumin as Curecumin:: From kitchen to clinic
Ajay Goel et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Phase II trial of curcumin in patients with advanced pancreatic cancer
Navneet Dhillon et al.
CLINICAL CANCER RESEARCH (2008)
Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-κB Inhibitor, Enhances Antitumor Activity of Taxanes in Anaplastic Thyroid Cancer Cells
Zhaowei Meng et al.
ENDOCRINOLOGY (2008)
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products
Ajaikumar B. Kunnumakkara et al.
CANCER RESEARCH (2007)
NF-κB in solid tumors
Francesco Pacifico et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
Hisatsugu Ohori et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death
A Arlt et al.
ONCOGENE (2003)
Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)
L Vermeulen et al.
EMBO JOURNAL (2003)
NF-κB regulation in the immune system
QT Li et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Inhibition of JNK activation through NF-κB target genes
GL Tang et al.
NATURE (2001)
Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II
D Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
